prostate cancer | Medivizor | source: Medivizor | Added May 21, 2023
War on Cancer: The Right Metaphor?
“For me, having lost my husband, it’s frustrating to hear publicly people saying to John McCain, ‘If anybody can beat this you can — you’re so tough.' Not that it’s intentionally hurtful, but it does leave those of us who’ve lost a loved one thinking, ‘Was my loved one not
breast cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added May 20, 2023
Evaluating the effectiveness and safety of sacituzumab govitecan versus chemotherapy in patients with HR+, HER2– metastatic breast cancer.
This study investigated the effectiveness and safety of sacituzumab govitecan (Trodelvy; SG) compared to chemotherapy in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (BC). The data showed that SG significantly improved survival without cancer progression compared to chemotherapy in these patients with manageable side effects.
prostate cancer | Medivizor | source: Medivizor | Added May 19, 2023
Oncology Basics 2016: DNA
The Central Dogma of Biology Doesn’t the title above sound imposing? Yet this central idea has moved biological science forward over the last 60 plus years. What we know about cells, genetics and cancer today relies on this "Dogma": DNA carries our hereditary information and transfers that information in abreast cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added May 18, 2023
Evaluating the effectiveness and safety of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine in patients with breast and gynecological cancer.
This study evaluated the effectiveness and safety of the Pfizer/BioNTech BNT162b2 COVID-19 vaccine in patients with breast and gynecological cancer. The data showed that most patients with breast and gynecological cancer developed antibodies after the second dose of the vaccine. However, the authors suggested that for non-responders or weak responders, additional immunization booster seems to be required, along with proactive planning in the vaccination schedule, with vaccine administration spaced out over time with respect to chemotherapy.
prostate cancer | Medivizor | source: Medivizor | Added May 17, 2023
Oncology Basics 2016: The Immune System and Immunotherapy
Oncology Basics 2016 continues with a look at the immune system and immunotherapy. As described in a previous post, one of the regulators of cell division and proliferation is the immune system. Harnessing the power of the immune system to attack and destroy cancer cells is a promising area of
breast cancer | Research | Lifestyle | 10 pages | source: Frontiers in oncology | Added May 16, 2023
Evaluating the effectiveness of physical exercise programs in breast cancer survivors on health-related quality of life, physical fitness, and body composition
The study evaluated the effectiveness of physical exercise (PE) programs in breast cancer (BC) survivors on health-related quality of life (HRQoL), physical fitness, and body composition. The study concluded that PE programs do have a positive impact on BC survivors’ HRQoL, physical fitness, and body composition.
stroke | Research | 10 pages | source: Scientific reports | Added May 15, 2023
Evaluating the risk factors for ischemic or hemorrhagic stroke recurrence
This study investigated the risk factors for ischemic or hemorrhagic stroke recurrence and the impact of antiplatelet therapy in patients with intracranial hemorrhage (ICH; brain bleed). The data showed that the risk of stroke recurrence is high in these patients. Hypertension (high blood pressure) is a risk factor for ischemic and hemorrhagic stroke recurrence. Antiplatelet therapy does not decrease the risk of ischemic stroke recurrence but may decrease the risk of hemorrhagic stroke recurrence.
prostate cancer | Medivizor | source: Medivizor | Added May 15, 2023
5 Facts You Probably Didn't Know About An Unappreciated Organ: The Bladder
Because of its lowly role in the human body, we think about our bladders only when something is going wrong or when we have to go really, really badly. So, November has been set aside as Bladder Health Awareness month. Here is a short review of bladder anatomy and functionbreast cancer | Research | Treatment | 10 pages | source: Scientific reports | Added May 14, 2023
Evaluating the effectiveness of massage therapy for chemotherapy-induced nerve disease
The study evaluated the effectiveness of massage therapy for chemotherapy-induced peripheral neuropathy (CIPN) in patients with breast and gastrointestinal (GI) cancer. The main finding of the study was that intensive massage therapy 3 times a week showed promising results in these patients.
breast cancer | Research | Treatment | 10 pages | source: Breast Cancer Research and Treatment | Added May 14, 2023
Evaluating the effectiveness of abemaciclib alone or in combination with tamoxifen in patients with HR+, HER2– metastatic breast cancer resistant to hormone therapy.
This study evaluated the effectiveness of abemaciclib (Verzenio) alone or in combination with tamoxifen (Nolvadex) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (BC) resistant to hormone therapy. The data showed that abemaciclib in combination with tamoxifen was more effective in improving the overall survival of these patients.
